Law Offices of Howard G. Smith Announces Investigation of SeraCare Life Sciences, Inc.
13 Febrero 2012 - 6:00PM
Business Wire
Law Offices of Howard G. Smith announces that it is
investigating potential claims against the Board of Directors of
SeraCare Life Sciences, Inc. (“SeraCare” or the “Company”)
(NASDAQ:SRLS) related to the proposed acquisition of the Company by
Linden Capital Partners. The transaction is valued at approximately
$82 million or $4.00 per share.
The investigation concerns whether the Board of Directors of
SeraCare breached their fiduciary duties to stockholders by failing
to adequately shop the Company before agreeing to enter into the
proposed transaction, and whether the Company has disclosed all
material information to shareholders about the transaction. The
Company has seen substantial recent growth. Its share price has sky
rocketed from $2.64 on October 4, 2011 to $3.58 on February 10,
2012. Further, at least one analyst has set a target price for the
Company’s stock at $5.00.
If you are a shareholder of SeraCare, if you have information or
would like to learn more about these claims, or if you wish to
discuss these matters or have any questions concerning this
announcement or your rights or interests with respect to these
matters, please contact Howard G. Smith, Esquire, of Law Offices of
Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem,
Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at
(888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or
visit our website at http://www.howardsmithlaw.com.
Seracare Life Sciences (NASDAQ:SRLS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Seracare Life Sciences (NASDAQ:SRLS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Seracare Life Sciences (MM) (NASDAQ): 0 recent articles
Más de Law Offices of Howard G. Smith Artículos de Noticias